Induced pluripotent stem cells to model and treat neurogenetic disorders - Test2 - elhamkhani - TriplyDB

Induced pluripotent stem cells to model and treat neurogenetic disorders

Induced pluripotent stem cells to model and treat neurogenetic disorders

http://www.wikidata.org/entity/Q36131883

about

Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes A multiplex high-throughput gene expression assay to simultaneously detect disease and functional markers in induced pluripotent stem cell-derived retinal pigment epithelium.Amyotrophic lateral sclerosis - cell based therapy and novel therapeutic development.Stem cell therapy: a look at current research, regulations, and remaining hurdles Autism spectrum disorders: emerging mechanisms and mechanism-based treatment.iPSC technology--Powerful hand for disease modeling and therapeutic screen Neural stem cells: are they the hope of a better life for patients with fetal-onset hydrocephalus?Disease modeling and drug screening for neurological diseases using human induced pluripotent stem cells.Modeling Neurological Diseases With Human Brain Organoids.

P2860

Q26866409-B1B10540-320B-4086-9CA7-DB4978792579 Q27023257-033AEA71-ED53-48A5-B818-5C99E4AE7F4E Q33975601-E6A21959-BA43-4B8D-8515-A3EE69C7F552 Q34241565-A2CBAD16-5CAB-4C7D-AF7C-B76A7D6AFD36 Q34688736-37F5A788-8B20-4BE7-85C3-21AE5B0AF417 Q35595728-356083A9-0AED-4C11-99E4-3777C13BA9EA Q36082427-649A78D8-0E0D-43A5-AB49-F2640C21CAA1 Q37727816-E8033510-6E98-4FFA-B758-6576790AAFEE Q38107799-BC45A6B8-3E68-4705-A27A-01565C4F6958 Q55231889-8B1CDE60-9641-463F-9DFA-89F7762AED9D

P2860

Induced pluripotent stem cells to model and treat neurogenetic disorders

http://www.wikidata.org/entity/Q36131883

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Induced pluripotent stem cells to model and treat neurogenetic disorders

@ast

Induced pluripotent stem cells to model and treat neurogenetic disorders

@en

type

label

Induced pluripotent stem cells to model and treat neurogenetic disorders

@ast

Induced pluripotent stem cells to model and treat neurogenetic disorders

@en

prefLabel

Induced pluripotent stem cells to model and treat neurogenetic disorders

@ast

Induced pluripotent stem cells to model and treat neurogenetic disorders

@en

P1433

Q36131883-54E16763-1746-4B60-BE4C-DB2957E4299D

P1476

Q36131883-C661E006-4B0D-4E46-8262-A50988F4D919

P2093

Q36131883-3BA791B3-54E4-4B32-9E66-AC2745A2CC5B

P275

Q36131883-F6CC041C-16F0-4A96-B789-85D21948473D

P2860

Q36131883-00CFDAB5-E731-414A-9D4B-132FF1D6FA11

Q36131883-00D961AA-F24C-4452-B155-A30E7959E9C2

Q36131883-01A4DD5E-6D13-4659-920C-86818A5BA1E0

Q36131883-037AEA32-A2E5-4016-B0E1-4AA24678A3BD

Q36131883-05B94AA0-AE52-40F8-88F9-C17D70AF867F

Q36131883-0689D87A-72A1-48DB-80B9-F8C38FB0A221

Q36131883-089410A6-3828-4ECF-B8CC-A00762B27D7E

Q36131883-08F14E79-32B8-4E06-943A-98FD4705935C

Q36131883-092E0592-CA13-4412-8617-35D1F9C79B00

Q36131883-0A4B9C09-BEB6-4BB2-A938-4C26CA8393A4

P304

Q36131883-6DA63739-DC50-4E61-9F62-96C7E6C7F043

P31

Q36131883-E8357903-9F25-4CD5-BE98-435C15B0BB12

P356

Q36131883-D3455C13-46C0-4FA8-AC8E-CE1846AF6270

P478

Q36131883-EDCE47A2-0F50-4266-829D-E191C6495370

P50

Q36131883-09DCA4B4-7A61-49C2-9306-1573E9C3E55B

P5008

Q36131883-162B58C1-2729-4615-9705-FC199EF507F8

P577

Q36131883-71BAFCD0-B802-438F-BA55-90E6C9DC1EC1

P5875

Q36131883-9C1871DC-3305-40CE-A150-601950CFD06D

P698

Q36131883-FBD5DD6C-2895-418C-ADFD-A44F15BB4677

P921

Q36131883-14816F34-7D78-4B4A-814C-ACD9B800D10A

Q36131883-7C41B7C2-2268-42C3-B8F6-0364852DA216

P932

Q36131883-123D2569-748C-4F49-932F-40A55C4C78BE

P356

P1433

Neural Plasticity

P1476

Induced pluripotent stem cells to model and treat neurogenetic disorders

@en

P2093

Laurie C Doering

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Machado-Joseph Disease: from first descriptions to new perspectives.

Parkinson's Disease: Genetics and Pathogenesis

Correction of fragile X syndrome in mice.

Neuroscience in the era of functional genomics and systems biology

Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress

Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells

CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome

Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

P304

346053

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/346053

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2012-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230659337

http://www.w3.org/2001/XMLSchema#string

P698

22888453

http://www.w3.org/2001/XMLSchema#string

P921

neurological disorder

P932

3409544

http://www.w3.org/2001/XMLSchema#string